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ABSTRACT : In the forty-four patients with esophageal cancer, serum carci-
noembryonic antigen (CEA) levels were evaluated between pre- and postoperative periods 
in comparison with patients between positive and negative tissue CEA staining. 
 Serum CEA levels were generally lower in patients with esophageal cancer and these 
showed less alteration in the postoperative period as compared with those in preoperative 
period. It is interest to emphasize that the survival following surgery in patients with 
negative tissue CEA staining in poor in this study. 
 This study indicated that low serum CEA levels were shown in spite of local production 
of CEA in cancer cells, reflecting a blockage to release CEA to blood stream. 
 It is believed that the variety of expression of cancer associated antigens is based on 
multiclonarity of cancer cells and/or alteration of expression of antigens with advances 
in tumor growth. However, it is dubious that CEA generated by carcinoma of the esophagus 
is indicative of aggressive behavior of the tumor and poor prognosis. Few reports are 
available in regard to expression of CEA antigen in patients with esophageal cancer. 
The pre-and postoperative CEA levels in patients with esophageal cancer remained 
unclear. 
 The purpose of this study is to clarify clinical values of CEA measurement in patients 
with esophageal cancers.
   MATERIALS AND METHODS 
 During the time from November 1983 to June 
1988, forty-four patients who underwent a re-
section of the esophagus for esophageal cancer 
at the First Department of Surgery, Nagasaki 
University Hospital were eligible for this study. 
The levels of serum CEA in the 44 patients were 
compared between pre-and postoperative peri-
ods, which were determined by a double 
antibody method'). Differentiation between 
normal and elevated CEA titers was based on 
5.0ng/1 as the upper normal concentration.
 Tissue-CEA levels were also evaluated by 
staining method. Paraffin-embedded tissue 
were left at 38CC for 30min, removed paraffin 
using xylen and treated with 0.3% H202/MeOH 
for blockage of endogenous perioxidase and 
with swine for blockage of nonspecific finding 
by normal animal serum. 
 Preincubation was carried out for 15 minutes 
with normal goat serum diluted to 1:20, after 
which the cells were incubated in speclfic rabbit 
serum for one hour at room temperature, 
Antisera to CEA, purchased from Dakogatts were 
diluted to 1:400 and incubated with a secondary 
antibody, goat antirabbit IgG for 30 minutes and
then with PAP complex for another 30 minutes. 
Staining was done with 3.3-diaminobenzidin 
4m, for 10-15 minutes and counterstaing with 
3 percent methyl green solution. Washing with 
PBS for 30 minutes was done between each step. 
 Positive staining of cells was regarded as over 
20 percent of cells.
          RESULTS 
 Table 1 showed an interrelation between 
positive tissue CEA and serum CEA. Most of 
esophageal cancers (67.9%) revealed positive 
tissue CEA staining. There was no close 
correalation between tissue CEA and serum CEA. 
 According to gross findings of esophageal 
cancer lesions as shown in Table 2, the degree 
of positive tissue CEA staining was dominant 
in ulcerative lesions and in view of histologic 
findings positive tissue CEA staining 
predominated in well and moderately differ-
entiated carcinomas with not statistically 
significant difference. As for growing patterns, 
positive tissue CEA staining was dominant in 
the moderately or marked infiltration types as 
shown in Table 2. With respect to disease 
stages, high frequency of positive tissue CEA 
staining was seen in advanced cases such as 
a2-a3 and/or n2-n4 as shown in Table 3. 
 Table 4 showed a relationship between 
positive tissue CEA staining and histologic 
findings of vascular invasion (ly, v) and 
intraepithelial spread (ie). Histologic finding of 
vascular invasion closely correlated with 
positive tissue-CEA staining. The survival time 
were compared in patients between patients 
with positive and nagative tissue CEA staining. 
 Fig. 1 showed a better survival curve in 
patients with positive tissue CEA staining. 
There was no surviors over 1.5 years in patients 
with negative tissue CEA staining as shown in 
Fig. 1. 
 The serum CEA levels in pre-and post-
operative periods were compared between 
patients with positive and negative tissue CEA 
staining as shown in Fig. 2. Elevation of serum 
CEA was not remarkable in patients with 
esophageal cancer. In terms of the degree of 
tissue CEA staving, there was no characteristics 
of changes in serum CEA between pre-and
Table 1. Relationship between serum CEA levels 
        and the degree of tissue CEA staining in 
        esophageal cancer 
               Serum CEA (-) Serum CEA (+) 
CEA STAIN - 7 0 
CEA STAIN + 23 4 
                                          N. S.
Table 2. Relationship of growth patters and cell 
        differentiation to tissue-CEA staining in
        esophageal cancer 
                    well. mod. poor. 
CEA STAIN - 0 6 1 
CEA STAIN + 14 20 3 
                                          N. S.
                     expan. mod. inv. mark. inv. 
 CEA STAIN - 1 5 1 
CEA STAIN + 7 18 12 
                                          N. S.
Table 3. Relationship between histologically can-
         cer extension and the degree of tissue
        CEA staining in esophageal cancer 
                aO al a2 a3 
CEA STAIN - 1 3 2 2 
CEA STAIN + 13 6 11 8 
                                          N. S.
                nO n1 n2 n3 n4 
CEA STAIN - 2 0 0 1 2 
CEA STAIN + 11 3 10 5 8 
                                          N. S.
Table 4. Relationship between histologically can-
        cer extension and tissue CEA staining
                 ly (-) ly (+) 
 CEA STAIN - 1 7 
CEA STAIN + 14 22 
                                          N. S.
                   v(-) v(+) 
CEA STAIN - 1 7 
CEA STAIN + 20 16 
                                  P<0.05
                 ie (-) ie (+)
 CEA STAIN - 4 3 
CEA STAIN + 22 15 
                                        N. S.
Fig. 1. The survival curve in comparison with 
      patients between positive and negative CEA 
      staining 
                      CEA STAIN
Fig. 2. Comparative observation of serum CEA 
       levels between pre-and postoperative peri-
      ods according to classification of the degree 
      of tissue CEA staining
postoperative periods. However, in patients 
with negative tissue CEA staining there was less 
reduction of serum CEA levels by surgical 
removal of the tumors.
         DISCUSSION 
 CEA is now widely utilized as markers of 
colorectal cancer. CEA is a glycoprotein antigen 
extracted from human colorectal cancer tissue 
and embryonal(2-6 months) intestinal tract by 
Gold et a12) in 1965. It is well known that CEA 
is one of the most useful marker to detect 
carcinoma, in partichlar, the appearance of 
recurrence in the course of postoperative 
follow-up study. Some reporters clarified that 
CEA is predictive of a presence of well 
differentiated carcinoma in the colon, stomach,
breast and lung. 
 It is argued that positive tissue CEA staining 
correlated with aggressive behavior of the 
tumor. It is recognized that generation of cancer 
associated antigen is generally promoted in 
advanced cancers. Rosenthal3) reported that 
CEA generation in culture cells is different from 
the parent cell line. It is controversial as to 
whether expression of cancer-associated anti-
gens closely represents aggressive behavior of 
the tumor. Some') reported a close correlation 
between expression of CEA and prognosis, 
others') reported no close correlation. 
 Hamadas) classified localization of tissue-CEA 
in colon cancers into the three types, Grade I 
(apical type), Grade II (cytoplasmic type), and 
Grade III (stromal type). He emphasized that 
serum-CEA levels increase in Grade III which 
includes the cases that are showing histologic 
finding of vascular invasion with poorly and 
moderate cell differentiations. 
 In general, marked elevation of serum CEA 
levels was not observed in patients with 
esophageal cancer. 
 Even after surgical removal of the tumor, 
serum CEA levels did not so much varied as 
to be predicted. It is a reflection that esophageal 
cancer lesions did not liberate CEA into the 
blood stream in spite of generation of CEA in 
cancerous lesions. 
 Interestingly enough, serum CEA levels in 
patients with negative tissue CEA staining were 
not influenced by surgical removal. It is 
accepted that serum CEA levels depend on a 
release of tissue CEA into the stroma8). 
 In this study, it was evidenced that most of 
carcinomas of the esophagus generate CEA in 
cancerous lesions. On the contrary, serum CEA 
levels in esophageal cancer were lower than 
those in other cancers. It is well known that 
CEA generation in cancer cells means aggressive 
growth, poor prognosis, depressed immuno-
responses and poor sensitivity to chemo-
therapy'). This finding seems to be corre-
sponded to clinical results of surgical treatment 
for esophageal cancers. 
 In contrast, Smith") reported that the prog-
nosis pf patients with breast cancer which 
showed strong tissue-CEA staing was favorable. 
Debate still continues regarding the clinical
significance of serum and tissue CEA levels in 
various cancers. 
 As far as esophageal cancer is concerned, this 
study indicated low serum CEA levels and high 
activity of CEA production in cancer cells. It 
is necessary to accumulate much study work 
on differentiation between serum and tissue 
CEA levels.
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